SB751 ensures that pharmaceutical manufacturers comply with the federal 340B Drug Pricing Program.
The House passed SB751 on May 17, 2024, by a vote of 133 to 18. We have assigned pluses to the nays because Section 340B of the Public Health Service Act, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices, is unconstitutional. Medicaid, along with the U.S. Department of Health and Human Services, is not authorized under Article I, Section 8, of the Constitution, as neither health care nor social welfare is the legitimate object of government. Government-subsidized health care or drug mandates, not to mention the ‘benefits’ provided to illegal aliens, are financed by immoral and anti-constitutional forms of taxation (e.g., personal or corporate income taxes) that violate the Bill of Rights and 14th Amendment by taking from citizens the wages they have rightfully earned. The General Assembly should act instead to nullify all unconstitutional federal laws and end reckless economic incentives.